Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.65    -1.40 (-1.75%)
Bid:
79.05
Ask:
79.70
Spread: 0.65 (0.822%)
Market Cap: £1.51b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

20 May 2026 07:00

RNS Number : 9800E
Coats Group PLC
20 May 2026
Β 

20 May 2026

Coats Group plc

AGM Trading Update

Robust performance year-to-date,

full-year expectations unchanged

Β 

Coats Group plc ('Coats' or the 'Group'), a world-leading Tier 2 supplier of critical components to the apparel and footwear industries, today announces a trading update for the four month period 1 January to 30 April 2026 (the 'period') ahead of its Annual General Meeting to be held later today.

Β 

Continuing operations

1st January to 30th April 2026 revenue versus same period in 2025

Organic CER

Reported

Apparel

1%

1%

Footwear

(4)%

55%

Group

(1)%

Β 18%

Β 

Β 

All following references are at organic constant exchange rates (CER) unless specified.

Β 

The Group delivered a robust performance with revenue 1% lower against a solid pre-tariff comparator period.

Β 

Apparel revenue was up 1%, strongly outperforming the core thread end market, driven by our key differentiators of operational agility, enduring customer relationships and our global manufacturing capabilities. The division continues to win market share across its portfolio including in China domestic and also saw strong growth in automotive thread.

Β 

In line with our expectations, Footwear revenue was 4% lower on an organic basis, which we estimate to be inline with industry trends, as customer caution persisted and inventory levels remained low. OrthoLite revenue was lower than the same period last year on a proforma basis against a very strong prior year comparator and temporary capacity challenges in Indonesia, where we are expanding our footprint. Our plans to realise cost synergies are on track and we are increasingly positive on sales synergies. We remain confident in OrthoLite's growth prospects.

Β 

Group EBIT margin was slightly higher than the same period last year, reflecting the benefits of the 2025 footprint consolidation in Footwear and the positive contribution from OrthoLite.

Β 

While the ongoing tensions in the Middle East have not had a material impact on trading to date, we are monitoring conditions closely. We have promptly enacted our well-honed operational and commercial playbook ensuring optimal pricing and cost discipline. We will continue to take action as required to mitigate supply chain pressures and raw material and energy cost increases.

Β 

Outlook

Β 

The Group's full year outlook remains unchanged with a modest second half profit weighting due to expected inflation cost recovery timing.

Β 

We expect full year free cash flow generation to remain strong, enabling the Group to continue to reduce leverage into our target range of 1-2x by year-end.

Β 

Β 

The Group will release its interim results on Tuesday 28 July 2026.Β 

Β 

Β 

Enquiry details

Investors

Chris Dyett

Coats Group plc

+44 (0) 7974 974 690

Media

Nick Hasell / Victoria Hayns

FTI Consulting

+44 (0)20 3727 1340

About Coats Group plc

Β 

Coats is a world-leading Tier 2 manufacturer and trusted partner for the apparel and footwear industries. We deliver essential materials, components, and software solutions that help our customers grow, compete and win.

Β 

With over 250 years of industry expertise, we're shaping the future of the apparel and footwear supply chain through insight-led innovation, impactful sustainability practices, and digital technologies that unlock better product quality, efficiency and performance.

Β 

Headquartered in the UK, Coats is a FTSE 250 company and a constituent of the FTSE4Good Index. In 2025, we generated $1.5 billion in revenue and employed c.19,000 people worldwide - all united by a spirit of innovation, quality and service. Learn more at www.coats.com or follow us on LinkedIn.

Β 

LEI: 2138003SPYWGAITNFY17

Β 

Cautionary statement

Β 

Certain statements in this trading update are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTAKCBNABKDNPD
Date   Source Headline
9th May 20252:33 pmRNSHolding(s) in Company
29th Apr 20251:26 pmRNSHolding(s) in Company
8th Apr 20252:58 pmRNSBlock listing Interim Review
7th Apr 20251:18 pmRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSStrategic exit from US Yarns
21st Mar 20252:21 pmRNSDirector/PDMR Shareholding
17th Mar 20252:00 pmRNSDirector/PDMR Shareholding
13th Mar 20253:20 pmRNSDirector/PDMR Shareholding
13th Mar 20257:19 amRNSAnnual Financial Report
10th Mar 20254:02 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNS2024 Full Year Results
7th Jan 20257:00 amRNSDirectorate Change
2nd Jan 20259:00 amRNSDirector Declaration
17th Dec 20241:16 pmRNSDirector/PDMR Shareholding
16th Dec 202411:04 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSTrading Statement
15th Oct 202412:41 pmRNSBlock listing Interim Review
9th Oct 20243:16 pmRNSDirector/PDMR Shareholding
17th Sep 202411:11 amRNSHolding(s) in Company
16th Sep 20241:19 pmRNSHolding(s) in Company
12th Sep 20249:37 amRNSHolding(s) in Company
6th Sep 20242:00 pmRNSDirector/PDMR Shareholding
5th Sep 20242:00 pmRNSDirector Declaration
4th Sep 20247:00 amRNSFinal de-risking of UK pension scheme
13th Aug 20241:15 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSDirectorate Change
1st Aug 20247:00 amRNSHalf-year Report
30th May 20247:00 amRNSDirectorate Change
22nd May 20244:33 pmRNSResult of AGM
22nd May 20247:00 amRNSTrading Statement
7th May 20241:16 pmRNSHolding(s) in Company
5th Apr 202410:50 amRNSBlock listing Interim Review
25th Mar 20242:16 pmRNSDirector/PDMR Shareholding
25th Mar 20242:15 pmRNSDirector/PDMR Shareholding
13th Mar 20243:55 pmRNSAnnual Financial Report
8th Mar 202412:27 pmRNSDirector/PDMR Shareholding
8th Mar 202412:25 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNS2023 Full Year Results
29th Feb 202410:03 amRNSHolding(s) in Company
29th Feb 20249:59 amRNSHolding(s) in Company
14th Dec 20232:13 pmRNSDirector Declaration
7th Dec 20237:00 amRNSSwitch off of Pension Deficit Repair Payments
22nd Nov 20237:00 amRNSTrading Statement
21st Nov 20239:22 amRNSHolding(s) in Company
16th Nov 20232:02 pmRNSHolding(s) in Company
15th Nov 20239:00 amRNSChange of Senior Independent Director
1st Nov 20231:38 pmRNSHolding(s) in Company
9th Oct 202312:10 pmRNSBlock listing Interim Review
5th Oct 20237:00 amRNSDirectorate Change
27th Sep 202312:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.